ACCUMULATION OF 1-METHYL-TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACID IN BLOOD AND ORGANS OF RAT - A POSSIBLE CAUSATIVE SUBSTANCE OF EOSINOPHILIA-MYALGIA-SYNDROME ASSOCIATED WITH INGESTION OF L-TRYPTOPHAN
Citation
Y. Ogawa et al., ACCUMULATION OF 1-METHYL-TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACID IN BLOOD AND ORGANS OF RAT - A POSSIBLE CAUSATIVE SUBSTANCE OF EOSINOPHILIA-MYALGIA-SYNDROME ASSOCIATED WITH INGESTION OF L-TRYPTOPHAN, Archives of toxicology, 67(4), 1993, pp. 290-293
Categorie Soggetti
Toxicology
SICI code
0340-5761(1993)67:4<290:AO1AI>2.0.ZU;2-G
Abstract
1-Methyl-tetrahydro-beta-carboline-3-carboxylic acid (MTCA) may cause
eosinophilia-myalgia syndrome (EMS) associated with ingestion of L-try
ptophan. The distribution and excretion of MTCA were studied in rats w
hich had received perorally a single 1.6 mg/kg dose of MTCA. MTCA conc
entrations in blood, kidney, liver, brain, heart, spleen, lung and gas
trocnemius muscle were measured by HPLC combined with fluorometric det
ection. The concentration of MTCA in each organ reached a maximum at 1
h and then gradually declined. However, a significant level of MTCA s
till remained at 5 h, when 52% of ingested MTCA remained in the conten
ts of the large intestine. Twenty-nine percent of the ingested MTCA wa
s excreted in urine over the course of 24 h. A higher dose (10 mg/kg)
of MTCA resulted in significant elevations in the concentrations and a
mounts of MTCA in the various organs. In addition, chronic treatment w
ith a 10 mg/kg dose of MTCA for 6 weeks further increased the concentr
ations and amounts of MTCA in each organ. However, no histological cha
nges were observed in any of the organs after chronic treatment. This
is the first report which demonstrates accumulation of MTCA in the blo
od and various organs, including muscle, of rats.